ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cyclizine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-30W8040
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Cyclizine Market Insights Forecast to 2028
BUY CHAPTERS

Global Cyclizine Market Research Report 2025

Code: QYRE-Auto-30W8040
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amoun Pharmaceutical
GlaxoSmithKline PLC
Pharmascript Limited
Advanz Pharma
TEVA
P and D Pharmaceuticals
Wabosan Arzneimittel
Aspen Pharmacare
Amco
AFT Pharmaceuticals
Be-Tabs Pharmaceuticals
Wockhardt UK

Cyclizine Market Size

The global market for Cyclizine was valued at US$ 1501 million in the year 2024 and is projected to reach a revised size of US$ 2089 million by 2031, growing at a CAGR of 4.9% during the forecast period.

Cyclizine Market

Cyclizine Market

Cyclizine, sold under a number of brand names, is a medication used to treat and prevent nausea, vomiting and dizziness due to motion sickness or vertigo. It may also be used for nausea after general anaesthesia or that which developed from opioid use.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cyclizine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyclizine.
The Cyclizine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cyclizine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyclizine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cyclizine Market Report

Report Metric Details
Report Name Cyclizine Market
Accounted market size in year US$ 1501 million
Forecasted market size in 2031 US$ 2089 million
CAGR 4.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Migraine
  • Motion Sickness
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amoun Pharmaceutical, Glaxosmithkline, Pharmascript Limited, Advanz Pharma, Teva, P and D Pharmaceuticals, Wabosan Arzneimittel, Aspen Pharmacare, Amco, Aft Pharmaceuticals, Be-Tabs Pharmaceuticals, Wockhardt UK
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cyclizine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cyclizine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cyclizine Market growing?

Ans: The Cyclizine Market witnessing a CAGR of 4.9% during the forecast period 2025-2031.

What is the Cyclizine Market size in 2031?

Ans: The Cyclizine Market size in 2031 will be US$ 2089 million.

Who are the main players in the Cyclizine Market report?

Ans: The main players in the Cyclizine Market are Amoun Pharmaceutical, Glaxosmithkline, Pharmascript Limited, Advanz Pharma, Teva, P and D Pharmaceuticals, Wabosan Arzneimittel, Aspen Pharmacare, Amco, Aft Pharmaceuticals, Be-Tabs Pharmaceuticals, Wockhardt UK

What are the Application segmentation covered in the Cyclizine Market report?

Ans: The Applications covered in the Cyclizine Market report are Migraine, Motion Sickness

What are the Type segmentation covered in the Cyclizine Market report?

Ans: The Types covered in the Cyclizine Market report are Oral, Injection

Recommended Reports

Prescription Drug Markets

Therapeutic Drug Markets

Anti-Infective & Safety

1 Cyclizine Market Overview
1.1 Product Definition
1.2 Cyclizine by Type
1.2.1 Global Cyclizine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Oral
1.2.3 Injection
1.3 Cyclizine by Application
1.3.1 Global Cyclizine Market Value by Application (2024 VS 2031)
1.3.2 Migraine
1.3.3 Motion Sickness
1.4 Global Cyclizine Market Size Estimates and Forecasts
1.4.1 Global Cyclizine Revenue 2020-2031
1.4.2 Global Cyclizine Sales 2020-2031
1.4.3 Global Cyclizine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cyclizine Market Competition by Manufacturers
2.1 Global Cyclizine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cyclizine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cyclizine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cyclizine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cyclizine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cyclizine, Product Type & Application
2.7 Global Key Manufacturers of Cyclizine, Date of Enter into This Industry
2.8 Global Cyclizine Market Competitive Situation and Trends
2.8.1 Global Cyclizine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cyclizine Players Market Share by Revenue
2.8.3 Global Cyclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cyclizine Market Scenario by Region
3.1 Global Cyclizine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cyclizine Sales by Region: 2020-2031
3.2.1 Global Cyclizine Sales by Region: 2020-2025
3.2.2 Global Cyclizine Sales by Region: 2026-2031
3.3 Global Cyclizine Revenue by Region: 2020-2031
3.3.1 Global Cyclizine Revenue by Region: 2020-2025
3.3.2 Global Cyclizine Revenue by Region: 2026-2031
3.4 North America Cyclizine Market Facts & Figures by Country
3.4.1 North America Cyclizine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cyclizine Sales by Country (2020-2031)
3.4.3 North America Cyclizine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cyclizine Market Facts & Figures by Country
3.5.1 Europe Cyclizine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cyclizine Sales by Country (2020-2031)
3.5.3 Europe Cyclizine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cyclizine Market Facts & Figures by Region
3.6.1 Asia Pacific Cyclizine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cyclizine Sales by Region (2020-2031)
3.6.3 Asia Pacific Cyclizine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cyclizine Market Facts & Figures by Country
3.7.1 Latin America Cyclizine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cyclizine Sales by Country (2020-2031)
3.7.3 Latin America Cyclizine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cyclizine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cyclizine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cyclizine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cyclizine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cyclizine Sales by Type (2020-2031)
4.1.1 Global Cyclizine Sales by Type (2020-2025)
4.1.2 Global Cyclizine Sales by Type (2026-2031)
4.1.3 Global Cyclizine Sales Market Share by Type (2020-2031)
4.2 Global Cyclizine Revenue by Type (2020-2031)
4.2.1 Global Cyclizine Revenue by Type (2020-2025)
4.2.2 Global Cyclizine Revenue by Type (2026-2031)
4.2.3 Global Cyclizine Revenue Market Share by Type (2020-2031)
4.3 Global Cyclizine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cyclizine Sales by Application (2020-2031)
5.1.1 Global Cyclizine Sales by Application (2020-2025)
5.1.2 Global Cyclizine Sales by Application (2026-2031)
5.1.3 Global Cyclizine Sales Market Share by Application (2020-2031)
5.2 Global Cyclizine Revenue by Application (2020-2031)
5.2.1 Global Cyclizine Revenue by Application (2020-2025)
5.2.2 Global Cyclizine Revenue by Application (2026-2031)
5.2.3 Global Cyclizine Revenue Market Share by Application (2020-2031)
5.3 Global Cyclizine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amoun Pharmaceutical
6.1.1 Amoun Pharmaceutical Company Information
6.1.2 Amoun Pharmaceutical Description and Business Overview
6.1.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amoun Pharmaceutical Cyclizine Product Portfolio
6.1.5 Amoun Pharmaceutical Recent Developments/Updates
6.2 Glaxosmithkline
6.2.1 Glaxosmithkline Company Information
6.2.2 Glaxosmithkline Description and Business Overview
6.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Glaxosmithkline Cyclizine Product Portfolio
6.2.5 Glaxosmithkline Recent Developments/Updates
6.3 Pharmascript Limited
6.3.1 Pharmascript Limited Company Information
6.3.2 Pharmascript Limited Description and Business Overview
6.3.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Pharmascript Limited Cyclizine Product Portfolio
6.3.5 Pharmascript Limited Recent Developments/Updates
6.4 Advanz Pharma
6.4.1 Advanz Pharma Company Information
6.4.2 Advanz Pharma Description and Business Overview
6.4.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Advanz Pharma Cyclizine Product Portfolio
6.4.5 Advanz Pharma Recent Developments/Updates
6.5 Teva
6.5.1 Teva Company Information
6.5.2 Teva Description and Business Overview
6.5.3 Teva Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Cyclizine Product Portfolio
6.5.5 Teva Recent Developments/Updates
6.6 P and D Pharmaceuticals
6.6.1 P and D Pharmaceuticals Company Information
6.6.2 P and D Pharmaceuticals Description and Business Overview
6.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.6.4 P and D Pharmaceuticals Cyclizine Product Portfolio
6.6.5 P and D Pharmaceuticals Recent Developments/Updates
6.7 Wabosan Arzneimittel
6.7.1 Wabosan Arzneimittel Company Information
6.7.2 Wabosan Arzneimittel Description and Business Overview
6.7.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Wabosan Arzneimittel Cyclizine Product Portfolio
6.7.5 Wabosan Arzneimittel Recent Developments/Updates
6.8 Aspen Pharmacare
6.8.1 Aspen Pharmacare Company Information
6.8.2 Aspen Pharmacare Description and Business Overview
6.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Aspen Pharmacare Cyclizine Product Portfolio
6.8.5 Aspen Pharmacare Recent Developments/Updates
6.9 Amco
6.9.1 Amco Company Information
6.9.2 Amco Description and Business Overview
6.9.3 Amco Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Amco Cyclizine Product Portfolio
6.9.5 Amco Recent Developments/Updates
6.10 Aft Pharmaceuticals
6.10.1 Aft Pharmaceuticals Company Information
6.10.2 Aft Pharmaceuticals Description and Business Overview
6.10.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Aft Pharmaceuticals Cyclizine Product Portfolio
6.10.5 Aft Pharmaceuticals Recent Developments/Updates
6.11 Be-Tabs Pharmaceuticals
6.11.1 Be-Tabs Pharmaceuticals Company Information
6.11.2 Be-Tabs Pharmaceuticals Description and Business Overview
6.11.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Be-Tabs Pharmaceuticals Cyclizine Product Portfolio
6.11.5 Be-Tabs Pharmaceuticals Recent Developments/Updates
6.12 Wockhardt UK
6.12.1 Wockhardt UK Company Information
6.12.2 Wockhardt UK Description and Business Overview
6.12.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Wockhardt UK Cyclizine Product Portfolio
6.12.5 Wockhardt UK Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cyclizine Industry Chain Analysis
7.2 Cyclizine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cyclizine Production Mode & Process Analysis
7.4 Cyclizine Sales and Marketing
7.4.1 Cyclizine Sales Channels
7.4.2 Cyclizine Distributors
7.5 Cyclizine Customer Analysis
8 Cyclizine Market Dynamics
8.1 Cyclizine Industry Trends
8.2 Cyclizine Market Drivers
8.3 Cyclizine Market Challenges
8.4 Cyclizine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Amoun Pharmaceutical
GlaxoSmithKline PLC
Pharmascript Limited
Advanz Pharma
TEVA
P and D Pharmaceuticals
Wabosan Arzneimittel
Aspen Pharmacare
Amco
AFT Pharmaceuticals
Be-Tabs Pharmaceuticals
Wockhardt UK
List of Tables
 Table 1. Global Cyclizine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cyclizine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cyclizine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cyclizine Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cyclizine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cyclizine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cyclizine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cyclizine Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cyclizine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cyclizine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cyclizine, Product Type & Application
 Table 12. Global Key Manufacturers of Cyclizine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cyclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyclizine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cyclizine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cyclizine Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cyclizine Sales Market Share by Region (2020-2025)
 Table 19. Global Cyclizine Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cyclizine Sales Market Share by Region (2026-2031)
 Table 21. Global Cyclizine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cyclizine Revenue Market Share by Region (2020-2025)
 Table 23. Global Cyclizine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cyclizine Revenue Market Share by Region (2026-2031)
 Table 25. North America Cyclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cyclizine Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cyclizine Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cyclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cyclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cyclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cyclizine Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cyclizine Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cyclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cyclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cyclizine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cyclizine Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cyclizine Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cyclizine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cyclizine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cyclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cyclizine Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cyclizine Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cyclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cyclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cyclizine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cyclizine Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cyclizine Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cyclizine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cyclizine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cyclizine Sales (K Units) by Type (2020-2025)
 Table 51. Global Cyclizine Sales (K Units) by Type (2026-2031)
 Table 52. Global Cyclizine Sales Market Share by Type (2020-2025)
 Table 53. Global Cyclizine Sales Market Share by Type (2026-2031)
 Table 54. Global Cyclizine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cyclizine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cyclizine Revenue Market Share by Type (2020-2025)
 Table 57. Global Cyclizine Revenue Market Share by Type (2026-2031)
 Table 58. Global Cyclizine Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cyclizine Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cyclizine Sales (K Units) by Application (2020-2025)
 Table 61. Global Cyclizine Sales (K Units) by Application (2026-2031)
 Table 62. Global Cyclizine Sales Market Share by Application (2020-2025)
 Table 63. Global Cyclizine Sales Market Share by Application (2026-2031)
 Table 64. Global Cyclizine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cyclizine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cyclizine Revenue Market Share by Application (2020-2025)
 Table 67. Global Cyclizine Revenue Market Share by Application (2026-2031)
 Table 68. Global Cyclizine Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cyclizine Price (US$/Unit) by Application (2026-2031)
 Table 70. Amoun Pharmaceutical Company Information
 Table 71. Amoun Pharmaceutical Description and Business Overview
 Table 72. Amoun Pharmaceutical Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amoun Pharmaceutical Cyclizine Product
 Table 74. Amoun Pharmaceutical Recent Developments/Updates
 Table 75. Glaxosmithkline Company Information
 Table 76. Glaxosmithkline Description and Business Overview
 Table 77. Glaxosmithkline Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Glaxosmithkline Cyclizine Product
 Table 79. Glaxosmithkline Recent Developments/Updates
 Table 80. Pharmascript Limited Company Information
 Table 81. Pharmascript Limited Description and Business Overview
 Table 82. Pharmascript Limited Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Pharmascript Limited Cyclizine Product
 Table 84. Pharmascript Limited Recent Developments/Updates
 Table 85. Advanz Pharma Company Information
 Table 86. Advanz Pharma Description and Business Overview
 Table 87. Advanz Pharma Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Advanz Pharma Cyclizine Product
 Table 89. Advanz Pharma Recent Developments/Updates
 Table 90. Teva Company Information
 Table 91. Teva Description and Business Overview
 Table 92. Teva Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Cyclizine Product
 Table 94. Teva Recent Developments/Updates
 Table 95. P and D Pharmaceuticals Company Information
 Table 96. P and D Pharmaceuticals Description and Business Overview
 Table 97. P and D Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. P and D Pharmaceuticals Cyclizine Product
 Table 99. P and D Pharmaceuticals Recent Developments/Updates
 Table 100. Wabosan Arzneimittel Company Information
 Table 101. Wabosan Arzneimittel Description and Business Overview
 Table 102. Wabosan Arzneimittel Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Wabosan Arzneimittel Cyclizine Product
 Table 104. Wabosan Arzneimittel Recent Developments/Updates
 Table 105. Aspen Pharmacare Company Information
 Table 106. Aspen Pharmacare Description and Business Overview
 Table 107. Aspen Pharmacare Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Aspen Pharmacare Cyclizine Product
 Table 109. Aspen Pharmacare Recent Developments/Updates
 Table 110. Amco Company Information
 Table 111. Amco Description and Business Overview
 Table 112. Amco Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Amco Cyclizine Product
 Table 114. Amco Recent Developments/Updates
 Table 115. Aft Pharmaceuticals Company Information
 Table 116. Aft Pharmaceuticals Description and Business Overview
 Table 117. Aft Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Aft Pharmaceuticals Cyclizine Product
 Table 119. Aft Pharmaceuticals Recent Developments/Updates
 Table 120. Be-Tabs Pharmaceuticals Company Information
 Table 121. Be-Tabs Pharmaceuticals Description and Business Overview
 Table 122. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Be-Tabs Pharmaceuticals Cyclizine Product
 Table 124. Be-Tabs Pharmaceuticals Recent Developments/Updates
 Table 125. Wockhardt UK Company Information
 Table 126. Wockhardt UK Description and Business Overview
 Table 127. Wockhardt UK Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Wockhardt UK Cyclizine Product
 Table 129. Wockhardt UK Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Cyclizine Distributors List
 Table 133. Cyclizine Customers List
 Table 134. Cyclizine Market Trends
 Table 135. Cyclizine Market Drivers
 Table 136. Cyclizine Market Challenges
 Table 137. Cyclizine Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cyclizine
 Figure 2. Global Cyclizine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cyclizine Market Share by Type: 2024 & 2031
 Figure 4. Oral Product Picture
 Figure 5. Injection Product Picture
 Figure 6. Global Cyclizine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cyclizine Market Share by Application: 2024 & 2031
 Figure 8. Migraine
 Figure 9. Motion Sickness
 Figure 10. Global Cyclizine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Cyclizine Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Cyclizine Sales (2020-2031) & (K Units)
 Figure 13. Global Cyclizine Average Price (US$/Unit) & (2020-2031)
 Figure 14. Cyclizine Report Years Considered
 Figure 15. Cyclizine Sales Share by Manufacturers in 2024
 Figure 16. Global Cyclizine Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Cyclizine Players: Market Share by Revenue in Cyclizine in 2024
 Figure 18. Cyclizine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Cyclizine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Cyclizine Sales Market Share by Country (2020-2031)
 Figure 21. North America Cyclizine Revenue Market Share by Country (2020-2031)
 Figure 22. United States Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Cyclizine Sales Market Share by Country (2020-2031)
 Figure 25. Europe Cyclizine Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Cyclizine Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Cyclizine Revenue Market Share by Region (2020-2031)
 Figure 33. China Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. China Taiwan Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Cyclizine Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Cyclizine Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Cyclizine Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Cyclizine Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Cyclizine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Cyclizine by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Cyclizine by Type (2020-2031)
 Figure 54. Global Cyclizine Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Cyclizine by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Cyclizine by Application (2020-2031)
 Figure 57. Global Cyclizine Price (US$/Unit) by Application (2020-2031)
 Figure 58. Cyclizine Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Buclizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cinnarizine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cinnarizine Tablets Market Research Report 2024
Global Scopolamine Market Insights Forecast to 2030
Hyoscine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nausea And Vomiting Treatment Market Insights Forecast to 2030
Dicyclomine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Flunarizine Hydrochloride Tablets Market Research Report 2024
Global Difenidol Hydrochloride Tablet Market Research Report 2024
Flunarizine Hydrochloride Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cyclobenzaprine Drug Market Insights Forecast to 2030
Global Ginger Root Supplement Market Research Report 2024
Global Pulse Antiemetic Device Market Research Report 2024
Antiemetic Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Motion Sickness Pills Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Household Pulse Antiemetic Device Market Research Report 2024
Dimenhydrinate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocetirizine Drug Market Insights Forecast to 2030
Global Ciclobenzaprina Market Research Report 2024
Global Amisulpride Acid Market Research Report 2024

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions